From Wikipedia, the free encyclopedia
  (Redirected from THDOC)
Jump to navigation Jump to search
Clinical data
CAS Number
PubChem CID
ECHA InfoCard100.008.457 Edit this at Wikidata
Chemical and physical data
Molar mass334.493 g/mol g·mol−1
3D model (JSmol)

Tetrahydrodeoxycorticosterone (abbreviated as THDOC; 3α,21-dihydroxy-5α-pregnan-20-one), also referred to as allotetrahydrocorticosterone, is an endogenous neurosteroid.[1] It is synthesized from the adrenal hormone deoxycorticosterone by the action of two enzymes, 5α-reductase type I and 3α-hydroxysteroid dehydrogenase.[2] THDOC is a potent positive allosteric modulator of the GABAA receptor, and has sedative, anxiolytic and anticonvulsant effects.[3][4][5] Changes in the normal levels of this steroid particularly during pregnancy and menstruation may be involved in some types of epilepsy (catamenial epilepsy) and premenstrual syndrome,[6] as well as stress, anxiety and depression.[7][8][9][10][11]


See also[edit]


  1. ^ Hosie, AM; Wilkins, ME; Da Silva, HM; Smart, TG (2006). "Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites". Nature. 444 (7118): 486–9. doi:10.1038/nature05324. PMID 17108970.
  2. ^ Agís-Balboa, RC; Pinna, G; Zhubi, A; Maloku, E; Veldic, M; Costa, E; Guidotti, A (2006). "Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis". Proc. Natl. Acad. Sci. U.S.A. 103 (39): 14602–7. doi:10.1073/pnas.0606544103. PMC 1600006. PMID 16984997.
  3. ^ Kokate, TG; Svensson, BE; Rogawski, MA (1994). "Anticonvulsant activity of neurosteroids: Correlation with gamma-aminobutyric acid-evoked chloride current potentiation". J. Pharmacol. Exp. Ther. 270 (3): 1223–9. PMID 7932175.
  4. ^ Reddy, DS; Rogawski, MA (2002). "Stress-induced deoxycorticosterone-derived neurosteroids modulate GABA(A) receptor function and seizure susceptibility". J. Neurosci. 22 (9): 3795–805. doi:10.1523/JNEUROSCI.22-09-03795.2002. PMID 11978855.
  5. ^ Reddy, DS (2003). "Pharmacology of endogenous neuroactive steroids". Crit. Rev. Neurobiol. 15 (3–4): 197–234. doi:10.1615/critrevneurobiol.v15.i34.20. PMID 15248811.
  6. ^ Tuveri, A; Paoletti, AM; Orrù, M; Melis, GB; Marotto, MF; Zedda, P; Marrosu, F; Sogliano, C; Marra, C; Biggio, G; Concas, A (2008). "Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy". Epilepsia. 49 (7): 1221–9. doi:10.1111/j.1528-1167.2008.01555.x. PMID 18325018.
  7. ^ Reddy, DS (2003). "Is there a physiological role for the neurosteroid THDOC in stress-sensitive conditions?". Trends Pharmacol. Sci. 24 (3): 103–6. doi:10.1016/S0165-6147(03)00023-3. PMID 12628349.
  8. ^ Reddy, DS (2006). "Physiological role of adrenal deoxycorticosterone-derived neuroactive steroids in stress-sensitive conditions". Neuroscience. 138 (3): 911–20. doi:10.1016/j.neuroscience.2005.10.016. PMID 16325348.
  9. ^ Eser, D; Romeo, E; Baghai, TC; Di Michele, F; Schüle, C; Pasini, A; Zwanzger, P; Padberg, F; Rupprecht, R (2006). "Neuroactive steroids as modulators of depression and anxiety". Neuroscience. 138 (3): 1041–8. doi:10.1016/j.neuroscience.2005.07.007. PMID 16310959.
  10. ^ Eser, D; Schüle, C; Baghai, TC; Romeo, E; Rupprecht, R (2006). "Neuroactive steroids in depression and anxiety disorders: Clinical studies" (PDF). Neuroendocrinology. 84 (4): 244–54. doi:10.1159/000097879. PMID 17159334.
  11. ^ Maguire, J; Mody, I (2007). "Neurosteroid synthesis-mediated regulation of GABA(A) receptors: Relevance to the ovarian cycle and stress". J. Neurosci. 27 (9): 2155–62. doi:10.1523/JNEUROSCI.4945-06.2007. PMID 17329412.